Eton Pharmaceutcials Inc (ETON) Stock Price, Quote & News

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 847 787 7361

Website: www.etonpharma.com

Address:

21925 W. Field Parkway, Suite 235, Deer Park, United States

losing_my_shirt Jul. 17 at 7:56 PM

$ETON id like to see this hold

0 · Reply

bryantboy99 Jul. 17 at 12:35 PM

$ETON somebody must have fat fingered a 5 share trade this morning.

0 · Reply

Chomo Jul. 17 at 2:28 AM

$ETON sellers showed on vwap from that high.

0 · Reply

A_Train1 Jul. 16 at 4:57 PM

$ETON how are we red??

1 · Reply

losing_my_shirt Jul. 16 at 12:59 AM

$ETON when this hits mid 12s load the boat

2 · Reply

A_Train1 Jul. 16 at 12:27 AM

$ETON did not expect this latest major downturn. Hold or cut bait? This is frustrating.

0 · Reply

RunsWithDogs Jul. 15 at 5:30 PM

$ETON I was unaware of the issues that the author points out in this new seekingalpha article: It probably explains the downdraft during the last few weeks. I'm not worried and looking to buy more, myself. https://seekingalpha.com/article/4801329-eton-pharma-near-term-catalysts-vanish

2 · Reply

RunsWithDogs Jul. 11 at 7:49 PM

$ETON What happened here the whole day? Other than no buyers, possibly due to the overall market drop. There's always algo selling with a falling tide. Better days ahead! Have a great weekend.

2 · Reply

A_Train1 Jul. 10 at 8:02 PM

$ETON what happened there at the end of the day? Geez.

0 · Reply

RunsWithDogs Jul. 8 at 7:44 PM

$ETON Nice! There's the 10% gain for the day. Hold it for 15 minutes and it's time for some outdoor time and a beer to celebrate.

0 · Reply

Eton Pharma Near Term Catalysts Vanish

Jul 8, 2025, 6:50 AM EDT - 9 days ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

Jun 27, 2025, 6:50 AM EDT - 20 days ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Jun 6, 2025, 5:26 PM EDT - 5 weeks ago

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

May 29, 2025, 12:42 PM EDT - 7 weeks ago

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

May 28, 2025, 5:28 PM EDT - 7 weeks ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 21, 2025, 2:57 AM EDT - 2 months ago

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

May 14, 2025, 4:30 PM EDT - 2 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025, 10:40 PM EDT - 2 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 2 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 2 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Apr 28, 2025, 6:50 AM EDT - 2 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Apr 1, 2025, 7:00 AM EDT - 3 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Mar 25, 2025, 2:30 AM EDT - 4 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

Mar 18, 2025, 7:42 PM EDT - 4 months ago

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:50 AM EDT - 4 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Mar 14, 2025, 6:50 AM EDT - 4 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Mar 4, 2025, 10:00 AM EST - 4 months ago

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Mar 4, 2025, 6:50 AM EST - 4 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Mar 3, 2025, 6:50 AM EST - 4 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Feb 7, 2025, 6:50 AM EST - 5 months ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Feb 6, 2025, 6:50 AM EST - 5 months ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Jan 3, 2025, 6:50 AM EST - 6 months ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Dec 20, 2024, 6:50 AM EST - 7 months ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Dec 3, 2024, 6:50 AM EST - 8 months ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 25, 2024, 6:50 AM EST - 8 months ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Nov 12, 2024, 8:01 PM EST - 8 months ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 8 months ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 9 months ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 3, 2024, 6:30 AM EDT - 10 months ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

Aug 22, 2024, 4:30 PM EDT - 11 months ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 11, 2024, 8:15 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 5:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

May 11, 2024, 9:34 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Apr 29, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 22, 2024, 2:20 AM EDT - 1 year ago

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

Mar 22, 2024, 2:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Mar 14, 2024, 9:38 PM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 29, 2024, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

Feb 21, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

Feb 2, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

Nov 9, 2023, 5:18 PM EST - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

Oct 30, 2023, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

losing_my_shirt Jul. 17 at 7:56 PM

$ETON id like to see this hold

0 · Reply

bryantboy99 Jul. 17 at 12:35 PM

$ETON somebody must have fat fingered a 5 share trade this morning.

0 · Reply

Chomo Jul. 17 at 2:28 AM

$ETON sellers showed on vwap from that high.

0 · Reply

A_Train1 Jul. 16 at 4:57 PM

$ETON how are we red??

1 · Reply

losing_my_shirt Jul. 16 at 12:59 AM

$ETON when this hits mid 12s load the boat

2 · Reply

A_Train1 Jul. 16 at 12:27 AM

$ETON did not expect this latest major downturn. Hold or cut bait? This is frustrating.

0 · Reply

RunsWithDogs Jul. 15 at 5:30 PM

2 · Reply

RunsWithDogs Jul. 11 at 7:49 PM

$ETON What happened here the whole day? Other than no buyers, possibly due to the overall market drop. There's always algo selling with a falling tide. Better days ahead! Have a great weekend.

2 · Reply

A_Train1 Jul. 10 at 8:02 PM

$ETON what happened there at the end of the day? Geez.

0 · Reply

RunsWithDogs Jul. 8 at 7:44 PM

$ETON Nice! There's the 10% gain for the day. Hold it for 15 minutes and it's time for some outdoor time and a beer to celebrate.

0 · Reply

RunsWithDogs Jul. 8 at 7:07 PM

$ETON Over average daily volume with power hour to come. I would love to see a 10% climb today!

0 · Reply

RunsWithDogs Jul. 8 at 5:40 PM

$ETON Amazing day so far despite the overall market being flat! More positive days to come as we get closer to earnings. I'm predicting 18 - 19 by mid-August and 20's in September as long as the whole market doesn't crater. GLTA

0 · Reply

bryantboy99 Jul. 8 at 12:30 PM

$ETON Sean and company are just killing it for patients and investors. Don't be afraid to jump in and join the fun.

1 · Reply

RunsWithDogs Jul. 8 at 12:22 PM

$ETON ET-600 Marketing Application Review announced this morning! https://seekingalpha.com/news/4465823-eton-stock-gains-new-therapy-gets-fda-review

0 · Reply

Aviso Jul. 8 at 12:11 PM

$BSGM $CRGX $CRVO $ETON

0 · Reply

briefingcom Jul. 8 at 11:58 AM

Gapping up: $BSGM +25.5% $CRGX +10.5% $CRVO +5.8% $ETON +3.9%

0 · Reply

BigSqueezeComing Jul. 8 at 11:16 AM

$ETON pt 17

0 · Reply

BigSqueezeComing Jul. 8 at 11:15 AM

$ETON Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) By Eton Pharmaceuticals | July 08, 2025, 6:50 AM

0 · Reply

Rage_Against_The_Machine Jul. 8 at 11:12 AM

$ETON's ET-600 NDA acceptance marks a critical step toward addressing pediatric diabetes insipidus. With patent protection through 2044 and first-mover potential in oral liquid dosing, this could be transformative. However, investors should note the stock's 48% YTD drop - execution risk remains high given the company's negative margins and $1.23 Debt/Equity. https://www.sec.gov/Archives/edgar/data/1710340/000143774925022298/eton20250702_8k.htm

1 · Reply

themacromindset Jul. 8 at 10:51 AM

$ETON - Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

0 · Reply

A_Train1 Jul. 7 at 7:37 PM

$ETON this seems like this action is just someone trying to pick up cheap shares.

0 · Reply

badgermobile Jul. 7 at 6:30 PM

$ETON volume is very low 234k which is half the 90 day average will end over 14 is my guess

0 · Reply

Market Cap	372.50M
Revenue (ttm)	39.01M
Net Income (ttm)	-3.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	32.79
Profit Margin	-9.79%
Debt to Equity Ratio	1.23

Volume	430,400
Avg Vol	515,496
Day's Range	N/A - N/A
Shares Out	26.82M
Stochastic %K	8%
Beta	1.18
Analysts	Strong Sell
Price Target	$29.67